Literature DB >> 9371858

Management of multiple sclerosis.

R A Rudick1, J A Cohen, B Weinstock-Guttman, R P Kinkel, R M Ransohoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9371858     DOI： 10.1056/NEJM199711273372207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

Review 1.  Stem cell transplantation for autoimmune diseases.

Authors:  J Moore; P Brooks
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Immunologic therapy for relapsing-remitting multiple sclerosis.

Authors:  H J MacLean; M S Freedman
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

3.  Focal neurologic deficit.

Authors:  F J Wippold
Journal:  AJNR Am J Neuroradiol       Date:  2008-11       Impact factor: 3.825

4.  Caregiver burden among informal caregivers assisting people with multiple sclerosis.

Authors:  Robert J Buchanan; Dagmar Radin; Chunfeng Huang
Journal:  Int J MS Care       Date:  2011

Review 5.  Translational research in neurology and neuroscience 2010: multiple sclerosis.

Authors:  Olaf Stüve; Bernd C Kieseier; Bernhard Hemmer; Hans-Peter Hartung; Amer Awad; Elliot M Frohman; Benjamin M Greenberg; Michael K Racke; Scott S Zamvil; J Theodore Phillips; Ralf Gold; Andrew Chan; Uwe Zettl; Ron Milo; Ellen Marder; Omar Khan; Todd N Eagar
Journal:  Arch Neurol       Date:  2010-07-12

Review 6.  Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.

Authors:  Mark Sanford; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

7.  Disulfiram and Diphenhydramine Hydrochloride Upregulate miR-30a to Suppress IL-17-Associated Autoimmune Inflammation.

Authors:  Ming Zhao; Dingya Sun; Yangtai Guan; Zhihong Wang; Daoqian Sang; Mingdong Liu; Yingyan Pu; Xue Fang; Dan Wang; Aijun Huang; Xiaoying Bi; Li Cao; Cheng He
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

Review 8.  Mitoxantrone: a review of its use in multiple sclerosis.

Authors:  Lesley J Scott; David P Figgitt
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.

Authors:  Marc Dauer; Katrin Pohl; Bianca Obermaier; Tobias Meskendahl; Julian Röbe; Max Schnurr; Stefan Endres; Andreas Eigler
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.